RICE HALL JAMES & ASSOCIATES, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 226 filers reported holding IMMUNOMEDICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$51,045,000
+54.3%
600,319
-35.7%
2.06%
+44.9%
Q2 2020$33,085,000
+131.3%
933,553
-12.0%
1.42%
+77.7%
Q1 2020$14,302,000
-35.7%
1,061,014
+0.9%
0.80%
+6.1%
Q4 2019$22,249,000
+72.1%
1,051,471
+7.9%
0.75%
+63.0%
Q3 2019$12,927,000
-6.2%
974,857
-1.9%
0.46%
+0.9%
Q2 2019$13,777,000
+11.1%
993,297
+53.9%
0.46%
+14.8%
Q1 2019$12,400,000645,5160.40%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders